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AbstrACt
Introduction Acute pancreatitis (AP) is a life- threatening 
inflammatory disease of the exocrine pancreas which 
needs acute hospitalisation. Despite its importance, we 
have significant lack of knowledge whether the lifestyle 
factors elevate or decrease the risk of AP or influence the 
disease outcome. So far, no synthetising study has been 
carried out examining associations between socioeconomic 
factors, dietary habits, physical activity, chronic stress, 
sleep quality and AP. Accordingly, LIFESPAN identifies risk 
factors of acute pancreatitis and helps to prepare preventive 
recommendations for lifestyle elements.
Methods and analysis LIFESPAN is an observational, 
multicentre international case–control study. Participating 
subjects will create case and control groups. The study 
protocol was designed according to the SPIRIT guideline. 
Patients in the case group (n=1700) have suffered 
from AP (alcohol- induced, n=500; biliary, n=500; 
hypertriglyceridemiainduced, n=200; other, n=500); the 
control group subjects have no AP in their medical history. 
Our study will have three major control groups (n=2200): 
hospital- based (n=500), population- based (n=500) and 
aetiology- based (alcohol, n=500; biliary, n=500 and 
hypertriglyceridemia, n=200). All of them will be matched 
to the case group individually by gender, age and location 
of residence. Aggregately, 3900 subjects will be enrolled 
into the study. The study participants will complete a 
complex questionnaire with the help of a clinical research 
administrator/study nurse. Analysis methods include analysis 
of the continuous and categorical values.
Ethics and dissemination The study has obtained 
the relevant ethical approval (54175-2/2018/EKU) and 
also internationally registered (ISRCTN25940508). After 
obtaining the final conclusions, we will publish the data 
to the medical community and will also disseminate our 
results via open access.
trial registration number ISRCTN25940508; Pre- results.
IntroduCtIon
Acute pancreatitis (AP) is a life- threatening 
inflammatory disease of the exocrine 
pancreas which needs acute hospitalisation. 
Despite its importance, we have significant 
lack of knowledge concerning whether life-
style factors elevate or decrease the risk of AP 
or influence the disease outcome. This insuf-
ficient information is even more problematic 
since (1) there is no specific treatment for the 
disease, therefore prevention would be very 
important; and (2) 20% of all AP is recurrent 
so lifestyle suggestions decreasing the risk of 
an additional attack could be highly efficient.
Genetic and environmental factors play a 
significant role in disease development and 
outcome. Of course, in most of the cases, the 
genetic background cannot be changed, but 
the environmental factors. Dietary habits, 
socioeconomic status, physical activity, stress 
strengths and limitations
 ► Innovative results are to be expected concerning 
that contribution of lifestyle factors to acute pan-
creatitis is poorly researched and known; therefore, 
evidence- based preventive suggestions might be 
carried out.
 ► LIFESPAN study will include a huge extension of 
examined patient population because of the three 
major control groups; all of them will be matched to 
the case group individually, and this will elevate the 
strength of our study.
 ► The study contains questionnaires only with no ad-
ditional costs; therefore, the study has an excellent 
cost:benefit ratio.
 ► The database will mostly consist of patient- delivered 
data.
 ► The questionnaire requires extensive time which 
needs plenty of attention from the administrators 
and subjects as well.
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or sleeping habits have been proven to play a crucial role 
in many diseases.
dietary factors
Association of diet and the risk of diseases is well known 
in a lot of diseases, for example, in type 2 diabetes 
mellitus1 2 and coronary heart disease,3 and there is an 
ongoing multicentre prospective study about diet and 
cancer by the European Prospective Investigation into 
Cancer and Nutrition (EPIC).4
Recently, a multiethnic cohort study was published 
about dietary factors that are associated with risk of 
pancreatitis.5 Data source was a retrospective multiethnic 
cohort in Hawaii and Los Angeles (215, 251 adult men 
and women were enrolled at the age of 45–75 years at 
baseline, from 1993 to 1996). They used hospitalisation 
claim files (1993–2012) to identify pancreatitis and a 
self- administered quantitative food frequency question-
naire.6 The main findings of this study are that intakes 
of saturated fat and cholesterol, and their food sources 
(red meat, eggs) positively associate with gallstone- related 
AP, intakes of fibre inversely associate with AP, intakes of 
vitamin D (mainly milk) inversely associate with gallstone- 
related AP and coffee consumption protects against AP 
(not related to gallstones).
The association of vegetable, fruit and fish consump-
tion with non- gallstone AP was examined in a Swedish 
prospective cohort study.7 8 Their conclusion is that vege-
table consumption, but not fruit consumption, may play 
a role in the prevention of non–gallstone- related AP, 
and the consumption of total fish may be associated with 
decreased risk of non–gallstone- related AP.
Physical activity
Several studies were published about physical activity 
and public health.9 10 Regular exercise offers protec-
tion against cardiovascular diseases and type 2 diabetes 
mellitus.11 So far, not many studies have investigated the 
association between general physical activity and AP, 
although there are some surprising case reports about 
marathon pancreatitis (extreme long- distance running 
results in AP).12 Results of a prospective cohort study 
show that there is an inverse association between physical 
activity and risk of AP.13
socioeconomic status
Socioeconomic status (SES) is strongly associated with 
risk of disease and mortality.14 SES includes the economic 
(measured by income), social (measured by education) 
and work status (measured by occupation). A clear rela-
tionship was also found between socioeconomic depriva-
tion and incidence of AP in a prospective observational 
study of AP in the North of England which was largely 
explained by a higher incidence of alcoholic aetiology.15
stress
Chronic stress may also cause disease, either because of 
molecular changes16 or because of increasing the proba-
bility of smoking, alcohol or drug consumption. Research 
shows that stress can contribute to the development of 
major illnesses, such as heart diseases, depression and 
obesity ( www. apa. org); however, no information is avail-
able concerning the effect of stress on the incidence of 
AP.
sleep quality
Currently, there are no studies about the association of 
sleep quality and AP; however, several articles claim that 
sleep deprivation or obstructive sleep apnoea is associated 
with elevated levels of C reactive protein,17 18 which is the 
stable marker of inflammation and usually high in AP.19
In this study, our aim is to examine these health- 
affecting individual lifestyle factors that seem to influence 
the development and outcome.
MEthods
The study has been initiated by the Hungarian Pancreatic 
Study Group and endorsed by the International Associ-
ation of Pancreatology and was structured following the 
SPIRIT 2013.20
design
LIFESPAN is an observational, multicentre and multina-
tional case–control study. The data collection is based on 
questionnaires and medical histories. Relevant data will 
be prospectively collected from patients and controls. 
The questionnaires A–F and P (seven questionnaires 
in the case group, six for the control group) about the 
different fields of the patients’ lifestyle will be filled with 
the help of trained administrators by a one- time meeting. 
Patients enrolled into the case group have suffered from 
AP; the control group subjects must not have AP in their 
medical history.
study organisation, committees and boards
The co- ordinator and designer of the LIFESPAN study is 
the Hungarian Pancreatic Study Group (HPSG—co- ordi-
nating society, https:// tm- centre. org/ en/ study- groups/ 
hungarian- pancreatic- study- group/). HPSG has been 
running high- quality international, multicentre clin-
ical trials since 201421–25 and has published the relevant 
guidelines for pancreatic diseases to improve patient care 
in pancreatology.26–29
The study will be supported by four committees:
steering committee (sC)
The committee will be led by PH (corresponding 
investigator, gastroenterologist and internal medicine 
specialist). The members will be in Szeged (HU): ED 
(principal investigator); Debrecen (HU): MP (gastroen-
terologist), ZV (gastroenterologist), TJ (gastroenterolo-
gist); Pécs (HU): AS (multidisciplinary unit specialist), 
DE (co- principal investigator), KM (trial management 
specialist), BE (gastroenterologist), ZG (public health 
specialist), JG (public health specialist), AV (gastroen-
terologist); Székesfehérvár (HU): FI (gastroenterolo-
gist), LG (gastroenterologist); Targu Mures (RO): IT 
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(gastroenterologist). KM is a trial management specialist, 
whereas AS leads the multidisciplinary core facility which 
will assist the scientists to run the study successfully.
International translational advisory board (ItAb)
The board will consist of a gastroenterologist (MML), a 
surgeon and two basic scientists (JN, MS- T, OHP). The 
ITAB will continuously monitor the progress of the study 
and will advise the SC.
data monitoring committee (dMC)
DMC will handle all the data and ensure that the data 
in the electronic case report form (eCRF) are accu-
rate, complete and legible. Data Management Plan will 
describe the detailed data flow. The Data Manager will 
validate the data from completed eCRFs, according to a 
Data Cleaning Plan. Any missing, implausible or incon-
sistent recordings in the eCRFs will be referred back to 
the Investigator using a data query form and be docu-
mented for each individual subject before clean file status 
is declared. All changes to eCRFs will be recorded. In case 
of important protocol modifications, DMC will report it 
to the SC.
Premature termination of the study
Interim analysis will be carried out after half of the 
presumed number of patients have completed the study. 
Sample sizes for all questionnaires will be reassessed and 
modified accordingly. In addition, DMC independently 
will assess the study- related documents and activities, with 
the aim of ensuring the respect of subjects’ right and to 
guarantee the plausibility of clinical data.
sponsor
The sponsor of the study is the Centre for Translational 
Medicine at the University of Pécs Medical School (co- or-
dinating institution and sponsor, www. tm- centre. org).
study population
All patients diagnosed with AP in participating institu-
tions will be informed concerning the possibility of taking 
part of the LIFESPAN study.
Case group (1700 cases): Patients in the case group 
will be divided into four groups depending on the caus-
ative agents of the AP (alcohol- induced, biliary, hypertri-
glycieridemia and other). Taking into consideration the 
central limit theorem,30 500 patients will be enrolled in 
all groups, but the hypertriglyceridemia- induced group, 
where due to the low prevalence level, only 200 subjects 
will be collected. With the sample size of 500, it is thought 
to be possible to safely analyse the relationship between 
two variables that contain up to four variable values  each. 
Altogether, we plan to enroll 1700 individuals as cases. 
This way, the required number of respondents can be 
provided for a comparative analysis between the members 
of the case and control groups as well as for an explor-
atory study within a given case group.
Control group (2200 cases)
Our study will have three major control groups; all of 
them will be matched to the case group individually in 
order to avoid admission rate bias.
(1) Hospital- based control group: we will enrol patients 
in other clinical departments (eg, Traumatology Depart-
ment, Ophthalmic Department, 500 patients); (2) 
Population- based control group: we will enrol people 
according to a plan based on gender:age:location of 
residence ratios in the case group (500 patients); (3) 
Aetiology- based control group: we will enrol people 
matched to the three aetiology factors of the four case 
groups (500, 500 and 200, respectively).
Inclusion criteria
The criteria for inclusion in the study in case groups (A) 
in general: (1) patients above 18 years; (2) diagnosed AP 
on the basis of the ‘2 out of 3’ rules of International Asso-
ciation of Pancreatology/American Pancreatic Associa-
tion (IAP/APA) guideline:
(a) upper abdominal pain; (b) serum amylase or lipase 
>3 times the upper limit of normal range; (c) character-
istic findings on pancreatic imaging; (3) written informed 
consent form is signed. According to the aetiology: (A1) 
in alcohol aetiology group: patients consuming >5 drinks 
per day or >35 drinks per week for both sexes (=8.75 
units per day; 61.25 units per week) shall be included. 
Please note that 1 unit of alcohol=10 mL or 8 g of pure 
(100%) alcohol31; (A2) in gallstone aetiology group: pres-
ence of gallstone (not sludge); (A3) in hypertriglycer-
idemia aetiology group: triglyceride level in blood over 
11 mmol/L32; (A4) in ‘other’ aetiology group: the caus-
ative agents do not match either of the first three groups, 
AP is induced by, for example, endoscopic retrograde 
cholangiopancreatography (ERCP) (post- ERCP pancre-
atitis), virus infection, trauma, medicine (drug- induced 
pancreatitis), congenital anatomical malformation, cystic 
fibrosis, genetics, gluten- sensitive enteropathy and so on.
The criteria for inclusion in the study for control groups 
(B, C and D) in general: (1) patients above 18 years; (2) 
absence of AP at present as well as in the medical history; 
(3) signed written informed consent form.
According to the aetiology of the case groups (b1)
In alcohol group: patients consuming >5 drinks per day 
or >35 drinks per week for both sexes (=8.75 units per day; 
61.25 units per week) shall be included. Please note that 
1 unit of alcohol=10 mL or 8 g of pure (100%) alcohol31; 
(B2) in gallstone group: presence of gallstone (not 
sludge); (B3) in hypertriglyceridemia group: triglyceride 
level over 11 mmol/L.32 The criteria for inclusion in the 
study for hospital- based control group (C): patients are 
hospitalised for other than internal medicine–associated 
disease, such as hospital admissions in Traumatology or 
Ophthalmic Department. The criterion for inclusion in 
the study for population- based control group (D): not 
hospitalised general population.
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Table 1 Title and source of the seven questionnaires to be used for data collection in LIFESPAN study
Form Title Source
Form A
(A1 and A2)
PERSONAL DETAILS, PHYSICAL 
AND SOCIOECONOMIC STATUS
National Health and Nutrition Examination Survey (NHANES 2015–2016);
American Community Survey (ACS);
The MacArthur Scale of Subjective Social Status
Form B
(B1 and B2)
DETAILS FROM THE MEDICAL 
HISTORY
Acute Pancreatitis Questionnaire (Registry for Pancreatic Patients by 
Hungarian Pancreatic Study Group)
Form C
(C1 and C2)
DIETARY HABITS Diet History Questionnaire, Version 2.0. National Institutes of Health, 
Epidemiology and Genomics Research Program, National Cancer Institute, 
2010
Form D
(D1 and D2)
PHYSICAL ACTIVITY International Physical Activity Questionnaire (long, usual week version)
Form E
(E1 and E2)
STRESS Percieved Stress Scale (10- item version)
Form F
(F1 and F2)
SLEEP QUALITY Pittsburgh Sleep Quality Index
Form P CHARACTERISTIC OF ACUTE 
PANCREATITIS (ONLY FOR CASE 
GROUP)
Acute Pancreatitis Questionnaire (see above)
ERCP, endoscopic retrograde cholangiopancreatography; IAP/APA, International Association of Pancreatology/American Pancreatic 
Association.
Exclusion criteria
The criteria for exclusion in all groups: (1) patients do 
not have reliable information or data; (2) patients may 
not adhere; (3) unclear aetiology.
Withdrawal of a subject from the study
According to the ethical regulations, individuals are 
allowed to leave the study at any time without any nega-
tive consequences. Patients in the case group will be 
recruited during their hospital stay. Individuals for the 
control group are either spread among different units or 
not hospitalised at all. In the study, the participants in the 
case and in the control groups will be matched individu-
ally and continuously by gender, age and residence. Age 
and sex will be matched precisely in each case; location of 
residence will be considered by the range of population. 
The length of the data collection is 6 years and the data 
analysis takes another half a year.
Data collection and follow- up: Each participant (3900), 
if he/she meets the inclusion criteria and signs the 
informed consent form, will be questioned by a clinical 
research administrator/study nurse who is fully trained 
before how to fill properly the questionnaires A–F and P. 
Since trained clinical research administrators will collect 
information, missing data will be unlikely. The schedule of 
enrolment and assessments will be carried out according 
to the SPIRIT Guideline (online supplementary figure 1).
In Form A (A1 and A2), we will collect general infor-
mation about personal details and current status. The 
subjective social status will be evaluated with the SES 
ladder (MacArthur Scale of Subjective Social Status, 
http://www. macses. ucsf. edu). It is a widespread instru-
ment in large epidemiological European and US studies 
and found to be significantly associated with health status, 
independently of objective socioeconomic indicators33 
(table 1).
In Form B (B1 and B2), we will collect information 
about patients’ medical history based on Acute Pancre-
atitis Questionnaire of the registry for pancreatic patients 
operated on by the Hungarian Pancreatic Study Group.34 
This online registry was established for recording data of 
patients with pancreatic diseases in 2012 ( www. tm- centre. 
org), including details on smoking, alcohol consumption, 
other risk factors, medical history and the course and 
outcome of the disease (table 1).
In Form C (C1 and C2), we will collect data about partic-
ipants’ dietary habits. Food Frequency Questionnaires 
(FFQs) are commonly used in epidemiological studies 
to assess the dietary intake of large populations. Their 
popularity derives from ease of administration, ability to 
assess dietary intake over a defined period of time and 
low costs.35 The Diet History Questionnaire II (DHQII) 
and Diet*Calc Analysis Software is a valid tool to measure 
dietary habits36–38 and free to use. It is a very detailed 
quantitative FFQ with the most general foods and drinks 
(table 1).
In Form D (D1 and D2), we will measure the participants’ 
physical activity (PA) level with a frequently used epide-
miology questionnaire, namely, the International Physical 
Activity Questionnaire.39 We will use the long, usual week 
version (27- item) in the general part of our PA question-
naire. It contains details about the participants’ vigorous 
PA, moderate PA, walking and sitting habits (table 1).
In Form E (E1 and E2), we will evaluate the participants’ 
chronic stress level with the Perceived Stress Scale.40 
It is the most widely used psychological instrument for 
the measuring of chronic stress effect.41–43 We chose the 
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10- item version which has high validity and reliability. 
The time range in the general part is different from the 
original questionnaire (last year vs last month) (table 1).
In Form F (F1 and F2), we will collect data about partici-
pants’ sleeping habits. We will apply the widely used Pitts-
burgh Sleep Quality Index (PSQI), which evaluates the 
participants’ sleeping quality.44 We skip the 10th question 
about bed partner or roommate because the bed partner 
will not be at the interview probably and this question 
does not count in the evaluation. The time range in the 
general part is also different from the original question-
naire (last year vs last month) (table 1).
In Form P, we will collect data about patients’ acute 
pancreatitis using the appropriate questions of Acute 
Pancreatitis Questionnaire (see Form B) (table 1).
Electronic case report forms will be developed and will 
be available online ( www. tm- centre. org).
Patient and public involvement
Ten individuals were involved in the testing procedure of 
the study in order to optimise the feasibility.
Endpoints
Endpoints will be provided by each question of the 
questionnaires.
Form A
Age, race, location, body weight, body height, body mass 
index (BMI), waist circumference, education, occupa-
tion, income, subjective social status.
Form B
Alcohol consumption (frequency, amount), smoking 
(frequency, amount), drug abuse (frequency, amount), 
diabetes mellitus (type), lipid metabolism disorder 
(type), any disease of the pancreas, pancreas, disorders in 
family history, congenital anatomical malformation of the 
pancreas, other illnesses, medications, diet.
Form C
A total of 176 nutrients, dietary constituents and food 
groups, carbohydrate constituents, macronutrients and 
energy, fats, fatty acids, cholesterol, protein constituents, 
vitamins, minerals, carotenoids and tocopherols, dietary 
constituents from supplements, other, food pyramid 
equivalents, Healthy Eating Index (HEI-2010) ((0–100); 
Good: >80, Needs improvement: 51–80; Poor: <51) (https://
www. cnpp. usda. gov/ sites/ default/ files/ healthy_ eating_ 
index/ HEI89- 90report. pdf) (table 2).
Form D
Continuous Scores (metabolic equivalent of task (MET)- 
minutes/week), Total physical activity (consists of Total 
walking activity (MET- minutes/week), Total moderate 
activity (MET- minutes/week), Total vigorous activity 
(MET- minutes/week), Average sitting (min/day)), Cate-
gorical score (level of PA: Low—This is the lowest level of 
physical activity. Those individuals who do not meet criteria for 
Categories 2 or 3 are considered to have a ‘low’ physical activity 
level. Moderate: 3 or more days of vigorous- intensity activity of 
at least 20 min per day OR 5 or more days of moderate- intensity 
activity and/or walking of at least 30 min per day OR 5 or 
more days of any combination of walking, moderate- intensity or 
vigorous intensity activities achieving a minimum Total phys-
ical activity of at least 600 MET- minutes/week. High: vigorous- 
intensity activity on at least 3 days achieving a minimum Total 
physical activity of at least 1500 MET- minutes/week OR 7 or 
more days of any combination of walking, moderate- intensity or 
vigorous- intensity activities achieving a minimum Total physical 
activity of at least 3000 MET- minutes/week) (https:// sites. 
google. com/ site/ theipaq/ scoring- protocol) (table 2).
Form E
Total Perceived Stress Scale (PSS) Score (0–40) (Catego-
ries: Low perceived stress—scores ranging from 0 to 13; Moderate 
perceived stress—scores ranging from 14 to 26; High perceived 
stress—scores ranging from 27 to 40) (https:// das. nh. gov/ 
wellness/ Docs/ Percieved_ Stress_ Scale. pdf) (table 2).
Form F
Global PSQI Score (0–21) (which consists of Subjective 
sleep quality (0–3): Sleep latency (0–3), Sleep duration (0–3), 
Habitual sleep efficiency (0–3), Sleep disturbances (0–3), Use of 
sleeping medication (0–3), Daytime dysfunction (0–3)), Cate-
gories (empirically derived cut- off score): Score <5: Good 
sleepers; Score >5: Poor sleepers (http:// uacc. arizona. edu/ 
sites/ default/ files/ psqi_ sleep_ questionnaire_ 1_ pg. pdf) 
(table 2).
Form P
Mortality, Severity (mild, moderate, severe), Complications 
(pancreatic, systemic).
statistical analysis
Variables
All variables will be identified according to the outcomes 
mentioned in Endpoints section. They are categorical, 
continuous and scaled variables. See below:
Form A: Analysis of the continuous and categorical 
values.
Form B: Analysis of the continuous and categorical 
values.
Form C: The Diet*Calc Analysis Program can evaluate 
the questionnaire data (https:// epi. grants. cancer. gov/ 
dhq2/ dietcalc).
Form D: We will use the official scoring protocol to eval-
uate the survey (https:// sites. google. com/ site/ theipaq/ 
scoring- protocol).
Form E: The original article contains the evaluation 
method40
Form F: The scoring instruction is described in the 
original article.44
Form P: Analysis of the continuous and categorical 
values.34
Bias
Deriving from the study design, a possible recall bias 
could occur (patients who have the outcome (cases) are 
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Table 2 Outputs, values, units and description of the Diet History Questionnaire II, the International Physical Activity 
Questionnaire, the Perceived Stress Scale and the Pittsburgh Sleep Quality Index
Questionnaire Outputs Values Unit Description
Eating habits:
Diet History Questionnaire 
II past year, with portion 
size
176 nutrients, dietary constituents and 
food groups
Varied Varied:
 ► µg
 ► mg
 ► g
 ► kcal
 ► IU, etc
Food groups:
 ► Carbohydrate 
constituents
 ► Macronutrients and 
energy
 ► Fats, fatty acids and 
cholesterol
 ► Protein constituents
 ► Vitamins
 ► Minerals
 ► Carotenoids and 
tocopherols
 ► Dietary constituents 
from supplements
 ► Other
 ► Food pyramid 
equivalents
HEI (Healthy Eating Index-2010) 0–100 Point Good: 80–100
Needs improvement: 
51–80
Poor: 0–51
Physical activity:
International Physical 
Activity Questionnaire 
long, last year version
Total walking activity 0– MET- minutes/week
OR kcal/week
Total moderate activity 0– MET- minutes/week
OR kcal/week
Total vigorous activity 0– MET- minutes/week
OR kcal/week
Total physical activity 0– MET- minutes/week
OR kcal/week
Sedentary activity 0- Hour and min/day
Level of physical activity Low
Moderate
High
NA Detailed description in 
the text above
Stress:
Percieved Stress Scale 
(PSS)
10- item version
Total general PSS score 0–40 Point Low perceived stress: 
0–13
Moderate perceived 
stress: 14–26
High perceived stress: 
27–40
Sleep:
Pittsburgh Sleep Quality 
Index (PSQI)
Component 1: Subjective sleep quality 0–3 Point 0- good, 3- bad
Component 2: Sleep latency 0–3 Point 0- good, 3- bad
Component 3: Sleep duration 0–3 Point 0- good, 3- bad
Component 4: Habitual sleep 
efficiency
0–3 Point 0- good, 3- bad
Component 5: Sleep disturbances 0–3 Point 0- good, 3- bad
Component 6: Use of sleeping 
medication
0–3 Point 0- good, 3- bad
Component 7: Daytime dysfunction 0–3 Point 0- good, 3- bad
Global PSQI score (general) 0–21 Point Good sleep quality: 0–5
Poor sleep quality: 5–21
MET, metabolic equivalent of task; NA, not applicable.
likely to remember the details of negative exposures more 
clearly than controls). It can be supposed that it appears 
randomly non- differential in the study groups.
Sample size
The sample size was originally calculated based on 
the end scores of the four questionnaires (HEI-2010, 
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International Physical Activity Questionnaire (IPAQ), 
PSS, PSQI). All calculations were made using a 5% signif-
icance level, a power of 80%, a 40% difference between 
the group means and equal sample size ratio (age, sex 
and socioeconomic- matched control groups). We used 
an online sample size calculator (http:// clincalc. com/ 
Stats/ SampleSize. aspx).
We achieved the required information, for example, 
mean and SD from articles (references found after each 
calculated sample size) or from online databases (HEI 
scores). In the case of two questionnaires (PSQI and 
PSS), we made the calculation based also on Hungarian 
and non- Hungarian data sources. The required sample 
sizes for the questionnaires per group are the following:
 ► HEI-2010 Score: 195 (National Health and Nutrition 
Examination Survey, 2011–2012, results in https://
www. cnpp. usda. gov/ healthyeatingindex);
 ► IPAQ Total activity: 15545;
 ► PSS Score: 217 and 13,46 2347;
 ► PSQI Score: 23148 187.49
Statistical methods
All the collected variables will be characterised using 
descriptive statistical method. Depending on the distribu-
tion, data will be represented as mean and SD or median 
with IQRs; categorical variables will be given in quantity 
and percentages.
In order to observe the differences, the endscores and 
subscale scores of the questionnaires, other parameters 
such as race, BMI, waist circumference, education, occu-
pation, income and subjective social status will be univar-
iately compared between the AP and the control groups. 
In case of binary outcomes, χ2 test in case of continuous 
variables, ANOVA or Kruskal- Wallis test with Bonferroni 
correction will be used provided by the distribution of the 
data.
Multivariable analysis will be applied to identify lifestyle 
factors that influence the risk of developing AP. To detect 
these factors, conditional logistic regression and multi-
variate mixed- effects linear regression will be performed 
where the matched pairs will be handled as random 
subjects.
The case groups and control groups will be matched by 
the next three criteria: age, gender and location. During 
the match, two controls will belong to each patient (case); 
the match tolerance will be set for age: ±5 years, gender: 
exact, location of residence: situated in the same country 
and ±15% of the population.
In order to identify possible patients’ outcomes (eg, 
severity of AP or mortality), the end scores of the ques-
tionnaires (DHQII, IPAQ, PSS, PSQI) and the variables 
from Forms A and B will be used in hierarchical cluster 
analysis using Ward’s method and the squared Euclidean 
distance.
For the effect of the parameters on survival, Kaplan- 
Meier survival analysis followed by multivariable Cox 
proportional- hazards model will be used among classes. 
We will calculate HR, relative risk (RR) and RR reductions 
with corresponding 95% CIs. All statistical analysis will be 
handled with a significance level of 5%.
dIsCussIon
This is the first study in which the relevant patient- 
reported retrospective data will be collected in a prospec-
tive manner, and the associations between socioeconomic 
factors, dietary habits, physical activity, chronic stress, 
sleep quality and AP will be investigated. We hope to 
find both negative and positive associations which will 
allow for the first time to suggest lifestyle modifications 
for patients discharged from the hospitals after AP or for 
those who wish to reduce their risk for AP.
Centres
The study will start with the following centres: Univer-
sity of Szeged, University of Pécs, University of Debrecen 
and Szent György University Teaching Hospital of Fejér 
County; however, other centres are welcome to partici-
pate in the LIFESPAN as an open- label study. Completion 
of the LETTER OF INTENT form will be mandatory for 
registering the participation of each institution. HPSG 
will acknowledge receipt of the LETTER OF INTENT 
form and will contact centres providing them with addi-
tional study information. Each centre must provide the 
same number of individuals for all the relevant four 
groups (one case and three controls).
Publication policy
Centres providing more than 40 individuals can provide 
an author to the authors’ list. Every additional 20 individ-
uals will give the opportunity to nominate an author.
dissemination policy
We plan to communicate the results to several members 
of the healthcare system including medical doctors, 
dietitians, nurses, patients and so on. We plan to publish 
the results in a peer- reviewed high- quality journal for 
professionals. In addition, we also plan to publish it for 
lay readers in order to maximise the dissemination and 
benefits of this study.
Feasibility and earlier experience
The feasibility will be examined by a pilot enrolment of 
20 individuals in each group.
safety
This is a non- interventional observational clinical study. 
Since no unknown drugs/therapy are used in the study, 
no adverse and serious adverse events are expected/inter-
pretable during the study.
Since no additional treatment is necessary for the study, 
the general healthcare costs are covered by the National 
Healthcare System (University of Pécs Medical School). 
This study was designed with the help of the Centre 
for Translational Medicine at the University of Pécs. 
This centre is committed to improve patients’ lives with 
research activities like registries, and observational and 
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interventional study organisations (https:// tm- centre. 
org). For joining centres, the additional local costs have 
to be covered by the centre.
trial status
Protocol version: V1.0 08.01.2019.
Start of patient recruitment: April 2019.
Planned finish of the study: 30 November 2023.
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